Loading…
Making diagnostic tests as essential as medicines
The global health community has focused on access to health products for prevention (vaccines) and treatment (medicines) over the last 20 years, but despite the consequences of underdiagnosis and misdiagnosis (including mistreatment, health complications and costly unnecessary interventions), there...
Saved in:
Published in: | BMJ global health 2018-08, Vol.3 (4), p.e001033-e001033 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The global health community has focused on access to health products for prevention (vaccines) and treatment (medicines) over the last 20 years, but despite the consequences of underdiagnosis and misdiagnosis (including mistreatment, health complications and costly unnecessary interventions), there has been very little focus in the global health dialogue to date on access to appropriate diagnostic tests to ensure appropriate treatment. Achieve universal health coverage (UHC), including financial risk protection, access to quality essential healthcare services and access to safe, effective, quality and affordable essential medicines and vaccines for all.6 Progress towards UHC means a lowering of barriers to seeking and receiving needed care: for example, out-of-pocket payments, distance, poorly equipped facilities and poorly trained health workers and receive the interventions currently agreed to be necessary.7 Access to diagnostic tests has to be a key part of this goal. First WHO prequalified hepatitis C rapid test opens the door to expanded treatment. http://www.who.int/medicines/news/prequal_hvc/en/ (accessed 15 May 2018). |
---|---|
ISSN: | 2059-7908 2059-7908 |
DOI: | 10.1136/bmjgh-2018-001033 |